Dr Atul Malhotra is a consultant neonatologist at Monash Newborn, Monash Children’s Hospital, a research fellow at The Ritchie Centre, Hudson Institute of Medical Research and a senior lecturer in the Department of Paediatrics, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University.
His clinical research interests focus on improving respiratory and neurological outcomes of high risk infants. He is the lead site investigator of a large NHMRC funded trial on neurodevelopment of the preterm infant, and recently established the early detection clinic for cerebral palsy at Monash Children’s Hospital. He has been instrumental in the translation of a number of preclinical therapies from the laboratory to the clinic. Recently, he led a world first trial on the use of placental stem cells in chronic lung disease of prematurity.
His basic science research interests include understanding and treating brain injury related to high risk perinatal conditions. He is about to complete his PhD, titled Novel therapy for intrauterine growth restriction related brain injury, with Associate Professor Suzie Miller and Professor Graham Jenkin at the Hudson Institute. He has been the recipient of a RACP fellowship; and is a chief investigator on a number of NHMRC and other competitive grants for his science work.
He is also heavily involved in medical education and simulation activities both at Monash Children’s Hospital and in low and middle income countries overseas. In particular, he regularly travels to India to facilitate simulation based education workshops for local health workers in obstetric and neonatal emergencies. This work has been supported by the Bill & Melinda Gates Foundation and the RACP.
Roberts CT, Owen LS, Manley BJ, Frøisland DH, Donath SM, Dalziel KM, Pritchard MA, Cartwright DW, Collins CL, Malhotra A, Davis PG. (2016) Nasal High Flow as Primary Respiratory Support for Preterm Infants. N Engl J Med Sep 22; 375(12):1142-51.
Malhotra A, Fahey MC, Miller SL, Jenkin G, Singh JV, Patil P, Kumar V, Wallace EM (2016) Developing a culturally sensitive training program for recognition of hypoxic ischemic encephalopathy in rural India. Int J Pediatr Res 2:024:1-4.
Gopagondanahalli KR, Li J, Fahey MC, Hunt RW, Jenkin G, Miller SL, Malhotra A (2016)Preterm hypoxic ischemic encephalopathy. Front Pediatr 4:114.
Alves de Alencar Rocha AK, Allison BJ, Yawno T, Polglase GR, Sutherland AE, Malhotra A, Jenkin G, Castillo-Melendez M, Miller SL (2017) Early- versus late-onset fetal growth restriction differentially affects development of the fetal sheep brain. Dev Neurosci. 39(1-4):141-155.
Malhotra A, Ditchfield M, Fahey MC, Castillo-Melendez M, Polglase GR, Allison BJ, Wallace EM, Hodges R, Jenkin G, Miller SL (2017) Detection and assessment of brain injury in the growth restricted fetus and neonate. Pediatr Res. Aug; 82(2):184-193.
Malhotra A, Fahey MC, Davies-Tuck M, Wong F, Carse E, Whiteley G, Ditchfield M (2017) Comparison of preterm and term equivalent age MRI for the evaluation of preterm brain injury. J Perinatol. Jul; 37(7):864-868.
Allison BJ, Hooper SB, Coia E, Jenkin G, Malhotra A, Zahra VA, Sehgal A, Kluckow M, Gill AW, Yawno T, Polglase, GR, Castillo-Melendez M, Miller SL (2017) Does fetal growth restriction increase the vulnerability to acute ventilation induced brain injury in newborn lambs? Implications for future health and disease. J Dev Orig Health Dis. Oct; 8(5):556-565.
McGrory L, Owen LS, Thio M, Dawson JA, Rafferty AR, Malhotra A, Davis PG, Kamlin COF (2018) A randomized trial of conditioned or unconditioned gases for stabilizing preterm infants at birth. J Pediatr Feb; 193:47-53.
Aridas JDS, Yawno T, Sutherland AE, Nitsos I, Ditchfield M, Wong FY, Hunt RW, Fahey MC, Malhotra A, Wallace EM, Jenkin G, Miller SL (2018) Systemic and transdermal melatonin administration prevents neuropathology in response to perinatal asphyxia in newborn lambs. J Pineal Res. May; 64(4):e12479.
Lim R*, Malhotra A*, Tan JL, Chan ST, Lau S, Zhu D, Mockler JC, Wallace EM (2018) First-in-human administration of allogeneic amnion cells in premature infants with bronchopulmonary dysplasia: a safety study. Stem Cells Transl Med Aug 5.